Phase II trial PD-L1/PD-1 blockade Avelumab (MSB0010718C) with Chemoradiotherapy for Locally Advanced Resectable T3b-4/N1-2 Rectal Cancer.
- Gill, Sanjeev (Primary Chief Investigator (PCI))
- Cross, Nikki (Project Manager)
Project: Research
Project: Research